Community-Based Remote Cardiac Rehabilitation Program for Pediatric Patients With Complex Congenital Heart Disease
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Mar 30, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new program to help children with complex congenital heart disease (CHD) get the rehabilitation they need from home. The program lasts for 12 weeks and includes both supervised and self-directed exercises to improve their heart health and physical fitness. The goal is to make cardiac rehabilitation more accessible for kids aged 8 to 18 years who have had heart surgery and are stable after their procedure. By using technology like smartwatches and video calls, the program aims to monitor their progress and ensure they are safe while exercising.
To be eligible for this study, children must be between 8 and 18 years old, have been diagnosed with complex CHD, and must have had their surgery at least three months prior. They also need to be able to use remote programs from home with the help of a caregiver. The trial will evaluate how well the program works and how safe it is by looking at various health measures and collecting feedback from the children and their parents. This is an important step toward providing better support for young patients with heart conditions in the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged between 8 and 18 years
- • 2. Diagnosed with complex congenital heart disease (Complex CHD) and have undergone surgery
- • 3. At least 3 months post-cardiac surgery with a stable hemodynamic status
- • 4. Capable of using remote programs (e.g., mobile apps, video-conferencing platforms) at home, with technical support from a caregiver
- • 5. Either the participant or their caregiver agrees to study participation and has signed the informed consent form
- Exclusion Criteria:
- • 1. Patients with uncontrolled arrhythmias, acute heart failure, myocarditis, pericarditis, or other ongoing cardiovascular conditions.
- • 2. Patients who are unable to exercise independently due to neurological or musculoskeletal disorders.
- • 3. Patients who cannot understand or carry out remote rehabilitation program instructions due to cognitive impairment.
- • 4. Patients showing clinically significant levels of depression or anxiety on the CDI-2 or RCMAS.
- • 5. Patients who cannot cooperate with required study assessments (e.g., CPET, ECG, 6MWT).
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported